Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles
暂无分享,去创建一个
I. Kwon | Y. Yeo | Sun Hwa Kim | J. Na | Kuiwon Choi | Jun-Pil Jee | Sangmin Lee
[1] Kwangmeyung Kim,et al. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[2] Lei Zhang,et al. Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. , 2012, ACS nano.
[3] G. Tiram,et al. Administration, distribution, metabolism and elimination of polymer therapeutics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[4] S. Rayala,et al. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications , 2012, International journal of nanomedicine.
[5] S. Parveen,et al. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[6] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[7] Kwangmeyung Kim,et al. Multifunctional Chitosan Nanoparticles for Tumor Imaging and Therapy , 2011 .
[8] Jesse V Jokerst,et al. Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.
[9] Hamidreza Ghandehari,et al. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[11] Beom Suk Lee,et al. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[12] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[13] Taro Kimura,et al. A poly(γ-glutamic acid)–amphiphile complex as a novel nanovehicle for drug delivery system , 2010, Journal of drug targeting.
[14] Qian Yang,et al. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. , 2010, Biomaterials.
[15] Jeong Won Lee,et al. Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.
[16] Kwangmeyung Kim,et al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[17] Nicholas A Peppas,et al. Targeted Nanodelivery of Drugs and Diagnostics. , 2010, Nano today.
[18] Ming-Jium Shieh,et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. , 2010, Bioconjugate chemistry.
[19] Ick Chan Kwon,et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. , 2010, Advanced drug delivery reviews.
[20] Ick Chan Kwon,et al. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. , 2010, Bioconjugate chemistry.
[21] Ick Chan Kwon,et al. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[22] W. Choe,et al. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[23] Liangfang Zhang,et al. Therapeutic nanoparticles to combat cancer drug resistance. , 2009, Current drug metabolism.
[24] Joseph M DeSimone,et al. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[25] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[26] Sen-ming Wang,et al. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier]. , 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[27] Byung-Heon Lee,et al. Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis , 2008, Journal of cellular and molecular medicine.
[28] T. Minko,et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[29] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[30] Y. Byun,et al. Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth. , 2008, Bioconjugate chemistry.
[31] Ick Chan Kwon,et al. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[32] I. Kwon,et al. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[33] Ick Chan Kwon,et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[34] K. Ulbrich,et al. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[35] Jing Zhao,et al. Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel , 2008, Nanotechnology.
[36] Kwangmeyung Kim,et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[37] B. Kelly,et al. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. , 2008, Molecular pharmaceutics.
[38] E. Kang,et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. , 2008, Biomaterials.
[39] Mark E. Davis,et al. Impact of tumor‐specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA‐containing nanoparticles , 2008, Biotechnology and bioengineering.
[40] Ick Chan Kwon,et al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[41] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[42] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[43] Gert Storm,et al. Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.
[44] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[45] Mansoor M. Amiji,et al. Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.
[46] J. Panda,et al. The present and future of nanotechnology in human health care. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[47] Daniel S Kohane,et al. Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.
[48] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[49] M. Rinaudo,et al. Chitin and chitosan: Properties and applications , 2006 .
[50] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[51] Robert Langer,et al. Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.
[52] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Junginger,et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[54] Ick Chan Kwon,et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[55] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[56] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[57] Kwangmeyung Kim,et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. , 2005, Biomacromolecules.
[58] J. Mano,et al. Chitosan-Based Particles as Controlled Drug Delivery Systems , 2004, Drug delivery.
[59] Ick Chan Kwon,et al. Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid , 2003 .
[60] I. Kwon,et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[61] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[62] R. Puri,et al. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[63] R. Puri,et al. Interleukin 4 Receptor on Human Lung Cancer , 2002 .
[64] Alexander V Kabanov,et al. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.
[65] A. Maitra,et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[66] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[67] Y Wang,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[68] Hiroshi Maeda,et al. Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues , 1998, Japanese journal of cancer research : Gann.
[69] C. Hawker,et al. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .
[70] Erkki Ruoslahti,et al. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.
[71] H. Rennke,et al. The Structural and Molecular Basis of Glomerular Filtration , 1978, Circulation research.
[72] Robert Blumenthal,et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.
[73] J. Dutta,et al. Chitin and chitosan: Chemistry, properties and applications , 2004 .
[74] J. Fernandes,et al. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[75] H. Junginger,et al. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. , 2002, Biomaterials.